Literature DB >> 7272885

Present status of clofibrate in Canada.

O J Lucis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7272885      PMCID： PMC1862171     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Effects of clofibrate on cholesterol metabolism.

Authors:  B J Kudchodkar; H S Sodhi; D L Horlick; D T Mason
Journal:  Clin Pharmacol Ther       Date:  1977-08       Impact factor: 6.875

2.  Clofibrate in coronary heart disease. Effect on morbidity and mortality.

Authors:  L R Krasno; G J Kidera
Journal:  JAMA       Date:  1972-02-14       Impact factor: 56.272

3.  Clofibrate and hyperlipidaemia.

Authors:  H Keen; B Lewis; N E Miller; V Wynn
Journal:  Lancet       Date:  1980-12-06       Impact factor: 79.321

4.  Mechanism of the hypolipemic effect of clofibrate in glucose-fed men.

Authors:  B M Wolfe; S P Ahuja; E B Marliss
Journal:  Metabolism       Date:  1980-03       Impact factor: 8.694

5.  High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs.

Authors:  M C Cheung; J J Albers; P W Wahl; W R Hazzard
Journal:  Atherosclerosis       Date:  1980-03       Impact factor: 5.162

6.  Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.

Authors:  B Vessby; H Lithell; I B Gustafsson; J Borberg
Journal:  Atherosclerosis       Date:  1979-08       Impact factor: 5.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.